ROLE OF SURGERY IN THE TREATMENT OF SMALL CELL LUNG CARCINOMA
https://doi.org/10.21294/1814-4861-2016-15-2-63-68
Abstract
The purpose of the study was to evaluate the role of surgery in the treatment of patients with small cell lung carcinoma in order to improve treatment outcomes. Material and methods. Long-term surgical treatment outcomes in 41 patients were analyzed. Twenty six patients underwent lobectomy and 15 patients underwent pneumonectomy. Results. The 5-year survival rates were 66, 29 and 21 % in patients with stage I, II and III small cell lung carcinoma, respectively. The 5-year survival rate following systematic lymph node dissection was significantly higher than following systematic biopsy (61 % versus 24 %). Conclusion. Surgical treatment including lobectomy or pneumonectomy with systematic lymph node dissection followed by adjuvant chemotherapy is recommended for patients with stage I and II small cell lung carcinoma.
About the Authors
А. А. Aksarin
Surgut Clinical Hospital, 14, Energetikov Street, 628408-Surgut
Russian Federation
Russian Federation
PhD, Head of Clinical-Diagnostic Cancer Center, Surgut Clinical Hospital (Surgut, Russian Federation). SPIN-code: 3942-3223.
М. D. Ter-Ovanesov
N.I. Pirogov Russian National Research Medical University, Moscow2
Russian Federation
Russian Federation
MD, DSc, Professor, Oncology and Radiation Therapy Department, Pediatric Faculty, N.I. Pirogov Russian National Research Medical University (Moscow, Russian Federation).
References
1. Bychkov M.B., Dgebuadze Je.N., Bol’shakova S.A. Small cell lung cancer.// Prakticheskaja onkologija. 2005. Vol. 6, № 4 (24). P. 213–219. [in Russian]
2. Davydov M.I., Gancev Sh.H., Lipatov O.N., Poljakov B.I., Rahmatulina I.R., Hanov A.M. Atlas onkology. M., 2008. 416 p. [in Russian]
3. Moiseev P.I. Combined treatment of patients with small cell lung cancer using postoperative chemotherapy and prophylactic irradiation of the brain // Onkologicheskij zhurnal. 2009. Vol. 3, № 1 (9). P. 21–25 [in Russian]
4. Moiseev P.I., Zharkov V.V. The role of surgery in combined treatment of patients with small cell lung cancer: own experience // Onkologicheskij zhurnal. 2007. Vol. 1, № 1 (1). P. 59–75. [in Russian]
5. Skripchak Ju.V., Kononova G.V., Asahin S.M., Levit M.L., Pushkareva I.K., Val’kov M.Ju. Radiation therapy for small cell lung cancer: evolution, current status and prospects // Sibirskij onkologicheskij zhurnal. 2011. № 6. P. 74–82. [in Russian]
6. The state of oncologic aid to the population of Khanty-Mansi Autonomous Okrug in 2013. Khanty-Mansiysk, 2014. P. 2. [in Russian]
7. Trahtenberg A.H., Chissov V.I. Lung cancer: guide, atlas. M., 2009. 655 p. [in Russian]
8. Brock M.V., Hooker C.M., Syphard J.E., Westra W., Xu L., Alberg A.J., Mason D., Baylin S.B., Herman J.G., Yung R.C., Brahmer J., Rudin C.M., Ettinger D.S., Yang S.C. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: its time has come // J. Thorac. Cardiovasc. Surg. 2005. Vol. 129 (1). P. 64–72.
9. Eberhardt W., Stamatis G., Stuschke M., Wilke H., Müller M.R., Kolks S., Flasshove M., Schütte J., Stahl M., Schlenger L., Budach V., Greschuchna D., Stüben G., Teschler H., Sack H., Seeber S. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial // Br. J. Cancer. 1999. Vol. 81 (7). P. 1206–1212.
10. Hann C.L., Rudin C.M. Management of Small-Cell Lung Cancer: Incremental Changes but Hope for the Future // Oncology (Williston Park). 2008. Vol. 22 (13). P. 1486–1492.
11. Isaka M., Nakagawa K., Ohde Y., Okumura T., Watanabe R., Ito I., Nakajima T., Kondo H. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma // Eur. J. Cardiothorac. Surg. 2012. Vol. 41 (4). P. 841–846. doi: 10.1093/ejcts/ezr132.
12. Jones C.D., Cummings I.G., Shipolini A.R., McCormack D.J. Does surgery improve prognosis in patients with small-cell lung carcinoma? // Interact. J. Thorac. Cardiovasc. Surg. 2013. Vol. 16 (3). P. 375–380. doi:10.1093/icvts/ivs475.
13. Ju M.H., Kim H.R., Kim J.B., Kim Y.H., Kim D.K., Park S.I. Surgical outcomes in small cell lung cancer // Korean J. Thorac. Cardiovasc Surg. 2012. Vol. 45 (1). P. 40–44. doi: 10.5090/kjtcs.2012.45.1.40.
14. Leuzzi G., Alessandrini G., Sperduti I., Spaggiari L., Venuta F., Rendina E., Granone P., Lococo F., Rapicetta C., Sgarbi G., Zannini P., Di Rienzo G., Nicolosi M., Facciolo F. Prognostic impact of node-spreading pattern in surgically-treated small-cell lung cancer: a multicentre analysis // Interact. J. Thorac. Cardiovasc. Surg. 2015. Vol. 21 (suppl. 1). P. S2–S3. doi: 10.1093/icvts/ivv204.06.
15. Lewiński T., Zulawski M., Turskil C., Pietraszek A. Small cell lung cancer I–IIIA: cytoreductive chemotherapy followed by resection with continuation of chemotherapy // Eur. J. Cardiothorac. Surg. 2001. Vol. 20 (2). P. 391–398.
16. Lucchi M., Mussi A., Fontanini G., Faviana P., Ribechini A., Angeletti C.A. Small cell lung carcinoma (SCLC): the angiogenic phenomenon // Eur. J. Cardiothorac. Surg. 2002. Vol. 21 (6). P. 1105–1110.
17. Rudin C.M., Ismaila N., Hann C.L., Malhotra N., Movsas B., Norris K., Pietanza M.C., Ramalingam S.S., Turrisi A.T., Giaccone G. Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline // J. Clin. Oncol. 2015. Vol. 33 (34). P. 4106–4111. doi:10.1200/jco.2015.63.7918.
18. Schreiber D., Rineer J., Weedon J., Vongtama D., Wortham A., Kim A., Han P., Choi K., Rotman M. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated? // Cancer. 2010. Vol. 116 (5). P. 1350–1357. doi: 10.1002/cncr.24853.
19. Yokouchi H., Ishida T., Yamazaki S., Kikuchi H., Oizumi S., Uramoto H., Tanaka F., Harada M., Akie K., Sugaya F., Fujita Y., Fukuhara T., Takamura K., Kojima T., Harada T., Higuchi M., Matsuura Y., Honjo O., Minami Y., Watanabe N., Nishihara H., Suzuki H., Dosaka-Akita H., Isobe H., Nishimura M., Munakata M. Prognostic impact of clinical variables on surgically resected small-cell lung cancer: Results of a retrospective multicenter analysis (FIGHT002A and HOT1301A).// Lung Cancer. 2015. Vol. 90 (3). P. 548–553. doi: 10.1016/j.lungcan.2015.10.010.
20. Yuequan J., Zhi Z., Chenmin X. Surgical Resection for Small Cell Lung Cancer: Pneumonectomy versus Lobectomy // ISRN Surg. 2012. Vol. 2012: 101024. doi: 10.5402/2012/101024.
21. Xu Y., Zheng H., Gao W., Jiang G., Xie H., Chen C., Fei K. Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer? // Interact. J. Cardiovasc. Thorac. Surg. 2014. Vol. 19 (6). P. 887–893. doi: 10.1093/icvts/ivu262.
Review
For citations:
Aksarin А.А., Ter-Ovanesov М.D. ROLE OF SURGERY IN THE TREATMENT OF SMALL CELL LUNG CARCINOMA. Siberian journal of oncology. 2016;15(2):63-68. (In Russ.) https://doi.org/10.21294/1814-4861-2016-15-2-63-68
Views:
2046
Email this article 
